The impact of the global bacille Calmette–Guérin shortage on treatment patterns: population‐based data

E-ISSN： 1464-410x|121|2|169-172

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.121, Iss.2, 2018-02, pp. : 169-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Thiotepa versus Bacille Calmette-Guérin in Non-Muscle Invasive Bladder Cancer

Current Urology, Vol. 6, Iss. 3, 2012-12 ,pp. : 160-164

Karger

Access to resources Recommend Favorite

Impact of Adjuvant Intravesical Bacillus Calmette-Guérin Treatment on Patients with High-Grade T1 Bladder Cancer

Urologia Internationalis, Vol. 96, Iss. 2, 2016-0 ,pp. : 136-141

Karger

Access to resources Recommend Favorite

The role of functional polymorphisms in immune response genes as biomarkers of bacille Calmette‐Guérin (BCG) immunotherapy outcome in bladder cancer: establishment of a predictive profile in a Southern Europe population

BJU INTERNATIONAL, Vol. 116, Iss. 5, 2015-11 ,pp. : 753-763

John Wiley & Sons Inc

Access to resources Recommend Favorite

Granulomatous hepatitis after intravesical bacillus Calmette–Guérin treatment

By Adami Maddalena Marsteller Igor Mazzucchelli Luca Cerny Andreas Bernasconi Enos

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 1, 2011-01 ,pp. : 55-57

Informa Healthcare

Access to resources Recommend Favorite

Nephrogenic Adenoma of the Bladder after Intravesical Bacillus Calmette-Guérin Treatment

Urologia Internationalis, Vol. 64, Iss. 4, 2006-01 ,pp. : 229-232

Karger

Access to resources Recommend Favorite